Vanda Pharmaceuticals Inc.VNDANASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank64
3Y CAGR-14.3%
5Y CAGR+6.8%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-14.3%/yr
vs +22.0%/yr prior
5Y CAGR
+6.8%/yr
Recent deceleration
Acceleration
-36.3pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $84.85M | -17.1% |
| 2024 | $102.32M | -24.7% |
| 2023 | $135.82M | +0.6% |
| 2022 | $135.03M | +159.3% |
| 2021 | $52.07M | -14.7% |
| 2020 | $61.03M | +35.4% |
| 2019 | $45.07M | -26.1% |
| 2018 | $61.01M | +81.4% |
| 2017 | $33.63M | -16.8% |
| 2016 | $40.43M | - |